IMM 1.45% 34.0¢ immutep limited

takeover?, page-6

  1. 3,661 Posts.
    lightbulb Created with Sketch. 311
    "I know that's a lot higher than where we are now, but don't under estimate the power of positive phase IIb results even if by then we have only interim data. I believe the final data for phase IIb should be out end of 2013. Not sure where I've seen that so someone please correct me if I am wrong."

    InToWin...as boiler correctly pointed out, the FDA would not have given Prima's Ph III CANVAS study the go ahead if they were not convinced the results of the Ph IIb warranted it.

    As John Butler says..."Don't believe the lies, read between the lines and critically analyse"!!!

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.